1 - 1 out of 1Page size: 10
  1. 2026

  2. The discovery of novel AKT inhibitor (4-(purin-6-yl)piperazin-1-yl)(benzofuran-2-yl)methanone for treatment of myeloid neoplasms: Computer modelling, synthesis and biological activity

    Semenov, K. N., Pimenova, E. V., Sokolov, V. A., Senichkina, D. А., Petukhova, N. V., Gureev, M. A., Platonova, E. Y., Bug, D. S., Pyatyisbyancev, T. A., Zhuravlev, A. S., Epifanovskaya, O. S., Gaponenko, I. N., Shakirova, A. I., Lepik, K. V., Porozov, Y. B., Isakova, V. A., Moiseev, I. S. & Sharoyko, V. V., 1 May 2026, In: Journal of Molecular Liquids. 449

    Research output: Contribution to journal › Article › peer-review

ID: 13802498